Global 
Australia 
België 
Deutschland 
España 
France 
Ireland 
Italia 
Luxembourg 
Nederland 
Österreich 
Portugal 
Россия 
Schweiz 
United Kingdom 
Get in touch
Meet our global team at our headquarters in Freiburg, Germany:
Dirk Brehmer, PhD
Head of Global Scientific Innovation and Partnering
February 19-22, 2025
ECCO - Berlin, Germany
May 3-6, 2025
DDW - San Diego, USA
June 16-19, 2025
Bio International Convention - Boston, USA
“As a scientist, drug hunter, biotech co-founder and bio/pharma leader, I strongly believe in the importance of trustful partnerships to combine and jointly advance internal and external innovations into transforming medicines aiming to help patients with their daily endeavor to manage their life.”
Dirk Brehmer, PhD
Contact details
dirk.brehmer@drfalkpharma.de
+49 761 47707370
About me
- PostDoc at the Zentrum for molecular biology (ZMBH), University of Heidelberg, Germany
- PhD thesis in Biochemistry & Molecular Biology with a focus on ligand induced protein folding and activity, University of Freiburg, Germany
- Diploma Degree in Chemistry by training, University of Freiburg, Germany
Guilhermina Carriche, PhD
Global Scientific Innovation and Partnering Manager
Innovation Champion Portugal & Spain (IBERIA)
February 19-22, 2025
ECCO - Berlin, Germany
March 17-19, 2025
Bio-Europe Spring - Milan, Italy
May 3-6, 2025
DDW - San Diego, USA
June 16-19, 2025
Bio International Convention - Boston, USA
“Our gastrointestinal system, apart from its main role in nutrient absorption, faces daily challenges to grant us tolerance to commensal and food antigens while fighting off pathogens. Environmental and genetic triggers can render our immune system weak. As a researcher, my goal was to understand how our immune cells orchestrate responses during health and disease. As an Innovation Champion for Dr. Falk Pharma, my goal is to conceptualize scientific knowledge into approaches that can make a difference in patients' lives.”
Guilhermina Carriche, PhD
Contact details
guilhermina.carriche@drfalkpharma.de
+49 151 64836426
About me
- B.Sc. Biochemistry, University of Minho, Portugal
- M.Sc. Cell and Molecular Biology, University of Porto, Portugal
- PhD Infection Biology/ Immunology, Hannover Medical School, Germany
- Postdoctoral fellow Weill Cornell Medicine, USA
Helle Størum
Head of Business Development
Innovation Champion Nordics
March 17-19, 2025
Bio-Europe Spring - Milan, Italy
March 25-26, 2025
Strategic Alliance Management Congress - Boston, USA
May 7-10, 2025
EASL Congress - Amsterdam, The Netherlands
June 16-19, 2025
Bio International Convention - Boston, USA
October 13-14, 2025
Nordic Life Science Days - Gothenburg, Sweden
“As a business developer, I am passionate about advancing the legacy of Dr. Falk Pharma and its unwavering commitment to helping patients battling gastrointestinal or liver diseases. I am eager to connect with companies with a similar focus and look forward to engaging in conversations about out-licensing and in-licensing opportunities.”
Helle Størum
Contact details
helle.stoerum@drfalkpharma.de
+49 160 6185586
About me
- Master of Science - Economics, International Marketing & Management, University of Southern Denmark
- Diploma in Pharmaceutical Medicine
Dr. Falk Pharma GmbH
Leinenweberstr. 5
79108 Freiburg
Germany
Email partnering@drfalkpharma.de
Phone: +49 (0)761 1514 0
Fax: +49 (0)761 1514 321
If you are looking for partnering contacts in other countries, please check our global site.
Stronger together
We continuously strive for transforming ideas and current advances in medical treatment. Dr. Falk Pharma cooperates with reliable partners in order to develop and implement high potential innovative treatment concepts. These can arise from any pharmacological concept: from “small molecules” to biologics. Within these projects, a wide variety of developmental steps are considered, which can have their origin in academic research, in clinical use, in start-ups or even established companies.
Dr. Falk Pharma is an industry leader in innovative pharmaceutical formulations that deliver active substances to specific functional segments of an inflamed gastrointestinal tract. Many of our products have attained standard-of-care status.
We enjoy an excellent reputation among academic and clinical key opinion leaders in the fields of gastroenterology, hepatology and proctology, resulting in strong, long-standing collaborations with renowned clinical centres.
As a partner, we offer comprehensive expertise across the entire value chain ranging from products and clinical development to regulatory approval, manufacturing and marketing.
We look forward to making new contacts and establishing new partners, both nationally and internationally, in the fields of digestive and metabolic medicine. Feel free to contact one of our Innovation Champions directly.
Photos: foto di matti